Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-21-001927
Filing Date
2021-03-31
Accepted
2021-03-31 17:17:05
Documents
131
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K curr_10k.htm 10-K 1693932
2 SUBSIDIARIES curr_ex211.htm EX-21.1 1723
3 CONSENT curr_ex231.htm EX-23.1 2170
4 CERTIFICATION curr_ex311.htm EX-31.1 10761
5 CERTIFICATION curr_ex312.htm EX-31.2 10593
6 CERTIFICATION curr_ex321.htm EX-32.1 4848
7 CERTIFICATION curr_ex322.htm EX-32.2 4840
14 curr_10kimg1.jpg GRAPHIC 2552
15 curr_ex231img1.jpg GRAPHIC 6405
  Complete submission text file 0001477932-21-001927.txt   9739164

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT curr-20201231.xml EX-101.INS 1819466
9 XBRL TAXONOMY EXTENSION SCHEMA curr-20201231.xsd EX-101.SCH 150625
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20201231_lab.xml EX-101.LAB 725214
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20201231_cal.xml EX-101.CAL 101789
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20201231_pre.xml EX-101.PRE 660471
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20201231_def.xml EX-101.DEF 397992
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55908 | Film No.: 21794630
SIC: 2834 Pharmaceutical Preparations